[Risks and precautions for the use of lamivudine in patients with chronic hepatitis B virus infection].
Andreani
Tony
T
Service d'Hépato-Gastroentérologie, Hôpital Saint-Antoine, Paris, France.
Chazouillères
Olivier
O
Calmus
Yvon
Y
Poupon
Raoul
R
D004279:DNA, Viral / Q000097:blood; D006509:Hepatitis B / Q000188:drug therapy*; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000188:drug therapy / Q000821:virology; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use; D019259:Lamivudine / Q000009:adverse effects* / Q000627:therapeutic use
D004279:DNA, Viral; D019259:Lamivudine; D007372:Interferons
Hépatite virale B: dangers et précautions d'emploi de la lamivudine.